Aspirin Tablet, Chewable
NDC Package 17714-009-36
Package Information
Aspirin tablets is this product does not contain directions or complete warnings for adult useadminister only under adult supervisionif possible, use weight to dose, otherwise use agerepeat dose every 4 hours while symptoms lastdo not give more than 5 doses in 24 hoursdrink water with each dose Weight (lbs.)Age (years)Dose77 – 8311 to under 124 – 6 tablets66 – 769 to under 114 - 5 tablets46 – 656 to under 94 tablets36 – 454 to under 63 tablets32 – 353 to under 42 tabletsunder 32under 3ask a doctorDRINK A FULL GLASS OF WATER WITH EACH DOSEadults and children 12 years and older :take 4 to 8 tablets every 4 hours while symptoms last, but not more than 48 tablets in 24 hours. This formulation utilizes a tablet, chewable delivery system. Marketed by Advance Pharmaceutical Inc., this product is identified by NDC 17714-009 and is authorized under FDA application M013.
Identification & Billing
- RxCUI: 318272 - aspirin 81 MG Chewable Tablet
- RxCUI: 318272 - ASA 81 MG Chewable Tablet
Clinical Specifications
- Anti-Inflammatory Agents, Non-Steroidal - [CS]
- Cyclooxygenase Inhibitors - [MoA] (Mechanism of Action)
- Decreased Platelet Aggregation - [PE] (Physiologic Effect)
- Decreased Prostaglandin Production - [PE] (Physiologic Effect)
- Nonsteroidal Anti-inflammatory Drug - [EPC] (Established Pharmacologic Class)
- Platelet Aggregation Inhibitor - [EPC] (Established Pharmacologic Class)
Regulatory & Marketing
Hierarchy Structure
- 17714 - Advance Pharmaceutical Inc.
- 17714-009 - Aspirin
- 17714-009-36 - 36 CARTON in 1 BOTTLE / 1 TABLET, CHEWABLE in 1 CARTON
- 17714-009 - Aspirin
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 17714-009-36 identifies a specific commercial package of 36 carton in 1 bottle / 1 tablet, chewable in 1 carton of Aspirin, a human over the counter drug labeled by Advance Pharmaceutical Inc.. This tablet, chewable is formulated for oral use and contains aspirin as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Advance Pharmaceutical Inc. on April 15, 1988. The current certification is valid through December 31, 2026.
How is this Advance Pharmaceutical Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 17714000936. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.